PALVELLA THERAPEUTICS
Palvella Therapeutics is a start-up life sciences company that focuses on relentlessly and selflessly serving abandoned patient populations with therapies. The company specializes in developing therapies that specifically target the root cause of the disease. Palvella Therapeutics was founded in 2015 and headquartered in Wayne, Pennsylvania.
PALVELLA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2015-01-01
Address:
Wayne, Pennsylvania, United States
Country:
United States
Website Url:
http://www.palvellatx.com
Total Employee:
1+
Status:
Active
Contact:
(484) 253-1460
Email Addresses:
[email protected]
Total Funding:
59.44 M USD
Technology used in webpage:
Amazon Route 53 Squarespace Hosted Mimecast
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Opaleye Management
Opaleye Management investment in Series C - Palvella Therapeutics
BioAdvance
BioAdvance investment in Series C - Palvella Therapeutics
Samsara BioCapital
Samsara BioCapital investment in Series C - Palvella Therapeutics
CAM Capital
CAM Capital investment in Series C - Palvella Therapeutics
BVF Partners
BVF Partners investment in Series C - Palvella Therapeutics
Adams Street Partners
Adams Street Partners investment in Series C - Palvella Therapeutics
Agent Capital
Agent Capital investment in Series C - Palvella Therapeutics
Ligand Pharmaceuticals
Ligand Pharmaceuticals investment in Series C - Palvella Therapeutics
Nolan Capital
Nolan Capital investment in Series C - Palvella Therapeutics
Ligand Pharmaceuticals
Ligand Pharmaceuticals investment in Corporate Round - Palvella Therapeutics
Official Site Inspections
http://www.palvellatx.com Semrush global rank: 4.83 M Semrush visits lastest month: 1.87 K
- Host name: 23.185.0.3
- IP address: 23.185.0.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Palvella Therapeutics"
Palvella Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Phone Number (484) 253-1460 Palvella Therapeutics is a start-up life sciences company that focuses on relentlessly and selflessly serving abandoned patient populations with therapies.See details»
Palvella Therapeutics - LinkedIn
Palvella Therapeutics and Pieris Pharmaceuticals announced a proposed merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on developing and commercializing novel ...See details»
Palvella Therapeutics, Inc. - Drug pipelines, Patents ... - Patsnap
Contact Information Investors Wesley H. Kaupinen Founder and CEO, Palvella Therapeutics [email protected] Media Marcy Nanus Managing Partner, Trilon Advisors, LLC …See details»
Investors - Palvella Therapeutics
Oct 15, 2024 November 7, 2024 in Uncategorized Palvella Therapeutics Announces First Patient Dosed in Phase 3 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of …See details»
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief …
Oct 17, 2024 Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, …See details»
Palvella Therapeutics - PitchBook
Palvella Therapeutics General Information Description. Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing novel …See details»
Palvella Therapeutics - Overview, News & Similar companies
Mar 9, 2023 View Palvella Therapeutics (www.palvellatx.com) location in Pennsylvania, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Palvella Therapeutics CEO and key executive team | Craft.co
Palvella Therapeutics's President and CEO is Wes Kaupinen. Other executives include Braham Shroot, Chief Scientific Officer; Kathy Goin, VP of Development Operations and 5 others. See …See details»
Advocacy / Partnerships - Palvella Therapeutics
National Organization for Rare Disorders NORD is a patient advocacy organization dedicated to individuals with rare diseases and the organizations that serve them. NORD, along with its …See details»
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief …
Oct 17, 2024 Korenberg currently serves on the board of directors, including the audit committee, of Lifecore Biomedical Inc. (NASDAQ: LFCR), a fully integrated contract …See details»
Palvella Therapeutics and Pieris Pharmaceuticals Reach Merger …
Jul 25, 2024 Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company specializing in novel treatments for rare genetic skin disorders without FDA-approved options, …See details»
Palvella Therapeutics Completes $45 Million Series C Financing
WAYNE, Pa., May 28, 2020 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a rare disease biopharmaceutical company focused on developing and commercializing pathogenetically …See details»
MedPharm Expands Partnership with Palvella
MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita MedPharm Ltd have …See details»
Palvella Therapeutics and Pieris Pharmaceuticals Announce …
Jul 24, 2024 Proposed merger to create a Nasdaq-listed, clinical-stage biopharmaceutical company focused on developing and commercializing novel treatments for serious, rare …See details»
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief
Oct 17, 2024 Mr. Korenberg is a seasoned operational and financial leader with more than 27 years of senior executive experience in biotech companies and healthcare investment …See details»
Palvella Therapeutics Reports Topline Results from Pivotal Phase 3 ...
WAYNE, Pa., July 20, 2023 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company developing and commercializing novel therapies to treat patients …See details»
Palvella Therapeutics Appoints Matthew E. Korenberg as Chief …
WAYNE, Pa., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Palvella Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to …See details»
Palvella Therapeutics Announces U.S. FDA Breakthrough
Nov 16, 2023 [email protected]. Media: Marcy Nanus Managing Partner, Trilon Advisors, LLC [email protected]. Tags breakthrough therapy ...See details»
Our Programs - Palvella Therapeutics
Microcystic Lymphatic Malformations (Micro LM) is a rare genetic disease of the lymphatic system characterized by abnormal vessels or cysts that lead to chronic lymphorrhea (abnormal flow of …See details»